Press release
Rosuvastatin Calcium Market 2018: Global Industry Analysis By Top Key Players (Bal Pharma, Cadila Pharmaceuticals, MSN Laboratories, Zhejiang Hisun Pharmaceutical)
Rosuvastatin Calcium
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
The worldwide market for Rosuvastatin Calcium is expected to grow at a CAGR of roughly 4.1% over the next five years, will reach 550 million US$ in 2023, from 430 million US$ in 2017.
Request for the sample copy: https://www.reporthive.com/enquiry.php?id=1584726&req_type=smpl
Market Segment by Manufacturers, this report covers
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm…And More
To Buy This Informative Research Report, Please click On the Link@ https://www.reporthive.com/enquiry.php?id=1584726&req_type=purch
Scope of the Report:
This report focuses on the Rosuvastatin Calcium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
With the raw material advantage, EU is the dominate producer and exporter in rosuvastatin calcium industry. The production market share of EU has reached about 35.25% in 2015. In additional, EU is also the largest
consumer of rosuvastatin calcium, about 34.47% of the global production was consumed in EU in 2015. China is the second producer with the market share of 28.82% in 2015. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55.09% of the total amount in 2015.
Market Segment by Type, covers
Purity 98.0%
Purity 99.0%
Other
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Applications, can be divided into
Tablet (including dispersible tablet and general tablet)
Capsule
Others
TABLES AND FIGURES
1 Market Overview
2 Manufacturers Profiles
3 Global Rosuvastatin Calcium Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
4 Global Rosuvastatin Calcium Market Analysis by Regions
5 North America Rosuvastatin Calcium by Countries
6 Europe Rosuvastatin Calcium by Countries…Toc Continued
About Report Hive Research
Report Hive Research delivers strategic market research reports, statistical survey, industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME’s, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio & application analysis etc.
500, North Michigan Avenue,
Suite 6014
Chicago, IL - 60611
United States
Contact Us
Mike Ross
Marketing Manager
sales@reporthive.com
http://www.reporthive.com
Phone Number: +1-312 604 7084
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rosuvastatin Calcium Market 2018: Global Industry Analysis By Top Key Players (Bal Pharma, Cadila Pharmaceuticals, MSN Laboratories, Zhejiang Hisun Pharmaceutical) here
News-ID: 1239947 • Views: …
More Releases from Report Hive Research
Oryzenin Market 2022 scope and Research methodology | Axiom Foods, Inc., AIDP
The global Oryzenin market is expected to reach an estimated USD 561.1 Million by 2030 with a CAGR of 14.2% from 2022 to 2030.
The Global Oryzenin market 2022 research provides a overview of the industry including definitions, classifications, applications and industry chain structure. The Global Oryzenin market report is provided for the US, EU, APAC, as well as development trends, competitive landscape analysis, and key regions development status. Development policies…
Polymer Emulsions Market SWOT Analysis, Competitive Landscape and Massive Growth …
The global Polymer Emulsions market was estimated at USD 27.3 billion in 2021 and is projected to expand at a CAGR of 7.5% from 2022 to 2030.
The Report Hive Research has added a new statistical market report to its repository titled as, Polymer Emulsions Market. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data…
Glufosinate Market Future Set to Significant Growth with High CAGR value 2022 | …
The global Glufosinate market is expected to reach an estimated USD 4.12 billion by 2030 with a CAGR of 8.68% from 2022 to 2030.
The Glufosinate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product…
Glass Filled Nylon Market 2022 scope and Research methodology | DowDuPont, BASF, …
The global Glass Filled Nylon market is projected to register an average CAGR of 5.6% during the forecast period 2022-2030.
The Global Glass Filled Nylon market 2022 research provides a overview of the industry including definitions, classifications, applications and industry chain structure. The Global Glass Filled Nylon market report is provided for the US, EU, APAC, as well as development trends, competitive landscape analysis, and key regions development status. Development policies…
More Releases for Rosuvastatin
Rosuvastatin Calcium Market Revenue, Insights, Overview, Outlook, Analysis | Val …
Rosuvastatin Calcium Market Size
The global Rosuvastatin Calcium revenue was US$ 525.7 million in 2022 and is forecast to a readjusted size of US$ 694.1 million by 2029 with a CAGR of 4.0% during the forecast period (2023-2029).
Get Free Sample @ https://reports.valuates.com/request/sample/QYRE-Auto-5S15779/Global_and_India_Rosuvastatin_Calcium_Market_Report_Forecast_2023_2029
In additional, EU is also the largest consumer of rosuvastatin calcium, about 34% of the global production was consumed in EU. China is the second producer with the market share…
Rosuvastatin Drugs to Boost the Revenue over the Forecast Period (2023-2028)|
Los Angeles, United States December 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Rosuvastatin Drugs market. It sheds light on how the global Rosuvastatin Drugs market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global…
Rosuvastatin Market Growth by Forecast 2022 - 2027 | Research Informatic
"Rosuvastatin market" research report is an expert's analysis which mainly includes companies, types, applications, regions, countries, etc. Also, the reports give an analysis of sales, revenue, trade, competition, investment, and forecast. Rosuvastatin market research covers COVID-19 impacts on the upstream, midstream, and downstream industries. Also, this study offers detailed market estimates by emphasizing statistics on several aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends.
Rosuvastatin,…
Rosuvastatin Calcium Market Size, Share, Demand and Forecasts Report till 2026
Rosuvastatin Calcium Market Overview:
Rosuvastatin Calcium Market Report Represents various segments related to generally state-of-the-art business data and industry future examples with cautious assessment and examination. Rosuvastatin Calcium Market driving the development of the existence sciences industry is altogether affecting business land in markets the nation over where this area has flourished. Clinical office, Lab and assembling space is rising quickly when different sorts of land, for example, office and retail…
Rosuvastatin Calcium Market Company Profiles, Financial Perspective 2026
The market research report published by QYResearch is a brilliant, in-depth, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Rosuvastatin Calcium market. It informs readers about key trends and opportunities in the global Rosuvastatin Calcium market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive…
China’s Rosuvastatin Market Growth, Sales Volume, Value, Share and Forecasts t …
Rosuvastatin was first developed by Japanese company Shionogi & Co., Ltd. in the late 1980s. In Jun. 1998, Shionogi & Co., Ltd. transferred the right to develop, market and sell Rosuvastatin worldwide to AstraZeneca. The development code of Rosuvastatin by AstraZeneca is ZD-4522. Rosuvastatin was first approved in the Netherlands on Nov. 7, 2002, approved by the Health Council of Canada in Feb. 2003, and by the FDA on Aug.…
